<qa>  What is the main benefit of the use of P-glycoprotein and Breast Cancer Re12. Concurrent or prior within 28 days of study day 1 use of strong P-glycoprotein and Breast Cancer Receptor Protein inhibitors including, but not limited to elacridar and valspodar. 